41-1
41st Parliament,
1st Session
(June 2, 2011 - September 13, 2013)
Select a different session
Meeting Detail
Study on prescription pharmaceuticals in Canada
Topic:
Witnesses
- Andrew Casey, President and Chief Executive Officer(BIOTECanada)
- Dr. Colin D'Cunha, Director, Global Medical Affairs, Apotex Inc.(Canadian Generic Pharmaceutical Association)
- Loretta Del Bosco, Director, Regulatory Affairs, Quality Assurance and Operations, Abbott Canada(BIOTECanada)
- Stan Glezer, Vice-President, Evidence, Value and Access, Sanofi(Rx&D)
- Ken Hughes, Vice-President, Scientific and Regulatory Affairs(Rx&D)
Meeting with interpretation and transcription